Company Filing History:
6 out of 24 
2 out of 5 
1 out of 1 Years Active: 2005-2011
Title: Victor Andrianov: A Pioneer in HDAC Inhibitor Inventions
Introduction:
Victor Andrianov, a renowned inventor based in Riga, LV, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of nine patents to his name, Victor Andrianov's work primarily focuses on the development of carbamic acid compounds as HDAC inhibitors. His inventions address various conditions mediated by HDAC, including cancer, proliferative conditions, and psoriasis. Let's delve into his groundbreaking contributions and explore some details about his career and collaborators.
HDAC Inhibitor Patents:
Victor Andrianov's latest patents revolve around carbamic acid compounds serving as HDAC inhibitors. One of his key inventions involves the discovery of specific carbamic acid compounds comprising a bicyclic heteroaryl group. These compounds have demonstrated the ability to inhibit HDAC activity, making them valuable in treating various conditions. Victor's patents highlight the chemical structures and compositions of these compounds, along with their pharmaceutically acceptable forms.
Another notable achievement by Victor Andrianov is his invention of carbamic acid compounds comprising an amide linkage as HDAC inhibitors. These compounds, characterized by the formula (1), have shown promise in inhibiting HDAC activity and possess potential applications in combating proliferative conditions like cancer and psoriasis.
Work Experience:
Victor Andrianov has held key positions in several prestigious companies throughout his career. Among them are TopoTarget UK Limited and Action Pharma A/S. TopoTarget UK Limited, a well-known pharmaceutical company, specializes in drug discovery and development. Action Pharma A/S is another prominent organization dedicated to the development of innovative pharmaceutical products. These experiences provided Victor with a solid foundation in the industry and further fueled his passion for groundbreaking research.
Collaborators:
Victor Andrianov has had the privilege of collaborating with esteemed professionals within the field of pharmaceutical research. Notably, he has worked alongside Paul W Finn and Ivars Kalvinsh, both of whom have contributed significantly to the advancements in HDAC inhibitor research.
Conclusion:
Victor Andrianov's prolific work in developing carbamic acid compounds as HDAC inhibitors has established him as a pioneer in the pharmaceutical industry. Through his patents, he has presented innovative solutions for various conditions mediated by HDAC, offering potential breakthroughs in the treatment of cancer, proliferative conditions, and psoriasis. With impressive collaborations and his work experience in renowned pharmaceutical companies, Victor continues to shape the future of HDAC inhibitor research.
Disclaimer: The information provided in this article is based on the available data on Victor Andrianov. For more comprehensive and up-to-date information, it is recommended to refer to official publications and sources related to his work and patents.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.